Paper Details

  1. Home
  2. Paper Details

JAK inhibitors and psoriatic arthritis: A systematic review and meta-analysis.

Author: BatticciottoAlberto, CampanaroFrancesco, CappelliAntonella, DonadiniMarco Paolo, SquizzatoAlessandro, ZaffaroniAndrea

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

While treatments for psoriatic arthritis (PsA) have improved in recent years, there's still a need for better options. This study examines the effectiveness and safety of JAK inhibitors, a new type of medication that targets specific pathways involved in PsA. The study focuses on two JAK inhibitors, tofacitinib and upadacitinib, which were recently approved for PsA treatment.
Paper Details　
Original Abstract of the Article :
Despite the therapeutic armamentarium for the treatment of psoriatic arthritis (PsA) has considerably expanded over the last thirty years, additional drugs are needed to improve care of this disease. JAK inhibitors (JAKinhibs) are small molecules able to interfere with the JAK/STAT pathway, involved...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.autrev.2021.102902

データ提供：米国国立医学図書館（NLM）

JAK Inhibitors: A New Oasis in the Desert of Psoriatic Arthritis

Psoriatic arthritis (PsA), a chronic inflammatory condition, can cause significant pain and disability. Imagine a desert traveler battling a relentless sandstorm, causing pain and hindering their ability to move freely. This research explores the potential of JAK inhibitors, a new class of drugs, to provide relief for individuals with PsA, offering a potential oasis in the desert of chronic inflammation.

A New Weapon: Combating the Sandstorm of Inflammation

The study examines the efficacy and safety of JAK inhibitors for treating PsA, finding that these drugs can effectively reduce inflammation and improve symptoms. Think of JAK inhibitors as a new weapon, capable of calming the sandstorm and restoring peace to the desert oasis of a patient's body.

A Brighter Horizon: Hope for Individuals with PsA

This research offers hope for individuals with PsA, providing evidence that JAK inhibitors can offer relief and improve quality of life. The study highlights the potential of these drugs to become a valuable tool in the management of PsA, providing a potential oasis in the desert of chronic inflammation and discomfort.

Dr. Camel's Conclusion

This research on JAK inhibitors offers a promising new approach for treating Psoriatic arthritis. Just as a desert traveler seeks a refreshing oasis to escape the heat and dust, these drugs provide a potential respite from the relentless sandstorm of inflammation. While further research is needed, this study offers a beacon of hope for individuals with PsA, paving the way for a brighter future in the management of this challenging condition.

Date :
  1. Date Completed 2021-09-28
  2. Date Revised 2022-01-28
Further Info :

Pubmed ID

34274542

DOI: Digital Object Identifier

10.1016/j.autrev.2021.102902

Related Literature

Article Analysis
・Effective treatment of psoriatic arthritis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.